C-reactive protein levels and subsequent cancer outcomes: Results from a prospective cohort study
- 30 April 2006
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 42 (6), 704-707
- https://doi.org/10.1016/j.ejca.2006.01.008
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition CohortCancer Epidemiology, Biomarkers & Prevention, 2005
- Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal CancerJAMA, 2005
- C-Reactive Protein Levels Are Not Associated with Increased Risk for Colorectal Cancer in WomenAnnals of Internal Medicine, 2005
- Colorectal Cancer and Serum C-reactive Protein Levels: a Case-control Study Nested in the JACC StudyJournal of Epidemiology, 2005
- C-Reactive Protein and the Risk of Incident Colorectal CancerJAMA, 2004
- No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancerThe Prostate, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997